PIPKI γ is highly expressed in the cancer tissues of CRC patients with poor prognosis, increases CCL2 expression through Akt-STAT3 signal activation, and recruits TAMs to the TME [114]. This evidence concerns the gene CCL2 and colorectal carcinoma.